Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Brian Godman

Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Brian Godman

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to conference › Poster › peer-review

9 Downloads (Pure)

Abstract

Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.

Original language	English
Number of pages	20
Publication status	Published - 29 Apr 2021
Event	Westminster Health Forum policy conference: Priorities for biosimilars in the NHS - development, regulation, commissioning and improving engagement - Held Online Duration: 29 Apr 2021 → 29 Apr 2021 https://www.westminsterforumprojects.co.uk/conferences/westminster-health-forum

Conference

Conference	Westminster Health Forum policy conference
Period	29/04/21 → 29/04/21
Internet address	https://www.westminsterforumprojects.co.uk/conferences/westminster-health-forum

Keywords

biosimilars
NHS
procurement
Europe

Access to Document

Godman-WHF-2021-Improving-medicines-value-for-money-in-the-NHSAccepted author manuscript, 693 KB

Cite this

@conference{f319dab3dabe4878a521d1833c12a4e3,

title = "Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far",

abstract = "Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.",

keywords = "biosimilars, NHS, procurement, Europe",

author = "Brian Godman",

year = "2021",

month = apr,

day = "29",

language = "English",

note = "Westminster Health Forum policy conference : Priorities for biosimilars in the NHS - development, regulation, commissioning and improving engagement ; Conference date: 29-04-2021 Through 29-04-2021",

url = "https://www.westminsterforumprojects.co.uk/conferences/westminster-health-forum",

}

TY - CONF

T1 - Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

AU - Godman, Brian

PY - 2021/4/29

Y1 - 2021/4/29

N2 - Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.

AB - Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.

KW - biosimilars

KW - NHS

KW - procurement

KW - Europe

UR - https://www.westminsterforumprojects.co.uk/conferences/westminster-health-forum

M3 - Poster

T2 - Westminster Health Forum policy conference

Y2 - 29 April 2021 through 29 April 2021

ER -

Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Abstract

Conference

Keywords

Access to Document

Other files and links

Fingerprint

Cite this